ArticleJMIR research protocols2026
Community-Based Hypertension Screening to Prevent Stroke in Underserved Urban Neighborhoods in French Guiana: Protocol for a Quasi-Experimental Study.
Article in JMIR research protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05814068 (Active Screening of Arterial Hypertension by Community Outreach Workers in the Cayenne Metropolitan Area to Reduce the Incidence of Cardiovascular Disease), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Active Screening of Arterial Hypertension by Community Outreach Workers in the Cayenne Metropolitan Area to Reduce the Incidence of Cardiovascular Disease
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHypertension is a leading contributor to stroke and cardiovascular disease in underserved populations.
objectiveThis study aims to evaluate a community-based hypertension screening intervention in French Guiana's precarious urban neighborhoods. This trial will assess whether a structured, community health mediator-led intervention reduces stroke incidence among adults residing in socioeconomically precarious areas of the Communauté d'Agglomération du Centre Littoral (CACL).
methodsThis is a 27-month, monocentric, quasi-experimental study conducted in the CACL, targeting neighborhoods classified as precarious. Adults aged ≥18 years will be included unless they are legally protected or decline participation. Trained mediators will deliver blood pressure screening and health education through mobile units and home visits over a 24-month period. Participants with elevated readings will receive referrals and structured follow-up. The primary outcome is the change in stroke incidence before and after the intervention, using Programme de Médicalisation des Systèmes d'Information (PMSI) hospitalization data. Secondary outcomes include changes in the rates of other cardiovascular and renal events and antihypertensive treatment adherence. Comparisons will use interrupted time series analysis, chi-square tests, and regression models. Missing data will be evaluated, and multiple imputation will be applied as needed.
resultsThis study was funded in 2022. Patient enrollment began in September 2023. As of September 4, 2025 (the end of field interventions), 23,289 participants had benefited from the intervention, including 10,901 (46.8%) who were formally enrolled and had completed questionnaires. Follow-up telephone calls were completed until December 2025. Data analysis is expected to be completed in the first quarter of 2026, with primary results anticipated to be published in 2026.
conclusionsThis study will determine whether a scalable, community-mediated hypertension screening intervention reduces stroke incidence in underserved populations.
trial registrationClinicalTrials.gov NCT05814068; https://clinicaltrials.gov/study/NCT05814068. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/89318.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.